219 related articles for article (PubMed ID: 16738185)
1. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
[TBL] [Abstract][Full Text] [Related]
2. Committee Opinion No. 601: Tamoxifen and uterine cancer.
Obstet Gynecol; 2014 Jun; 123(6):1394-1397. PubMed ID: 24848920
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
4. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
5. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
Neri F; Maggino T
Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
[TBL] [Abstract][Full Text] [Related]
7. Endometrial damage by antiestrogens in a postmenopausal breast cancer patient.
Ceci O; Bettocchi S; Marello F; Pellegrino A; Impedovo L; Di Venere R
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):174-5. PubMed ID: 11942911
[No Abstract] [Full Text] [Related]
8. A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.
Dede M; Gezginç K; Ulubay M; Alanbay I; Güran S; Yenen M
Eur J Gynaecol Oncol; 2008; 29(2):200. PubMed ID: 18459568
[TBL] [Abstract][Full Text] [Related]
9. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
Gupta M; Kiruthiga KG
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
[TBL] [Abstract][Full Text] [Related]
10. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
11. The effect of tamoxifen on the endometrium.
Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
[TBL] [Abstract][Full Text] [Related]
12. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Zhu Y; Yang J
J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697
[TBL] [Abstract][Full Text] [Related]
13. [The effects of tamoxifen on the female genital tract].
Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
[TBL] [Abstract][Full Text] [Related]
14. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
15. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract][Full Text] [Related]
16. [Effects of raloxifene on other organs without bone: uterus].
Nozaki M
Clin Calcium; 2004 Oct; 14(10):55-60. PubMed ID: 15577132
[TBL] [Abstract][Full Text] [Related]
17. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
Shi H; Chen X; Lv B; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
[TBL] [Abstract][Full Text] [Related]
18. Controversy about uterine effects and safety of SERMs: the saga continues.
Goldstein SR
Menopause; 2002; 9(5):381-4. PubMed ID: 12218728
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-induced endometrial cancer.
Chen P; Yang CC; Chen YJ; Wang PH
Eur J Gynaecol Oncol; 2003; 24(2):135-7. PubMed ID: 12701962
[TBL] [Abstract][Full Text] [Related]
20. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
